IP will support your market access team to gain a baseline understanding of EMR system visibility for your product across priority hospitals and community practices, in order to understand patient access at the point of care. A combination of qualitative and quantitative research methodologies will assess and monitor the placement of your product within major oncology/hematology EMR systems, in order to identify opportunities and barriers to patient access, and monitor changes over time.